Stocks
Thursday, 30 Nov 2023
DUOPHARMA BIOTECH BERHAD
- Board : Main
- Stock Code : 7148
- 52 Week High : 1.680
- 52 Week Low : 1.110
| Open | High | Low | Last | Chg | Chg % | Vol ('00) | Buy/Vol ('00) | Sell/Vol ('00) |
| 1.210 | 1.210 | 1.190 | 1.210 | -0.010 | -0.82 | 5,283 | 1.190 / 500 | 1.240 / 347 |
Log in to save your chart settings and more
- View Chart:
- 3 months
- 1 day
Financial Results
| Date Announced |
Financial Year End |
QTR | Period End | Revenue RM (,000) |
P&L RM (,000) |
EPS |
| 08 Nov 2023 | 31 Dec 2023 | 3 | 30 Sep 2023 | 169,235 | 8,970 | .93 |
| 24 Aug 2023 | 31 Dec 2023 | 2 | 30 Jun 2023 | 167,516 | 12,541 | 1.31 |
| 22 May 2023 | 31 Dec 2023 | 1 | 31 Mar 2023 | 200,475 | 22,633 | 2.38 |
| 23 Feb 2023 | 31 Dec 2022 | 4 | 31 Dec 2022 | 151,960 | 17,161 | 1.80 |
| 15 Feb 2022 | 31 Dec 2021 | 4 | 31 Dec 2021 | 145,444 | 15,716 | 1.67 |
DUOPHARMA BIOTECH BERHAD
The Company manufactures distributes imports and exports pharmaceutical products and medicines.
Address
SUITE 18.06, LEVEL 18, CIMB HUB,NO. 26, JALAN SULTAN ISMAIL,KUALA LUMPUR, FEDERAL TERRITORY
Malaysia
Contact
(60) 3 2162 0218
(60) 3 2161 0507
| 31 Dec 2020RM'000 | 31 Dec 2021RM'000 | 31 Dec 2022RM'000 | |
| Income Statement | |||
| Net Turnover/Net Sales | 569,902 | 639,175 | 696,717 |
| EBITDA | 110,103 | 120,823 | 129,380 |
| EBIT | 81,036 | 88,861 | 93,183 |
| Net Profit | 58,610 | 65,683 | 70,112 |
| BALANCE SHEET | |||
| Intangibles | 35,066 | 39,524 | 43,980 |
| Fixed Assets | 362,798 | 464,025 | 504,442 |
| Long Term Investment | - | - | - |
| Stocks/Inventories | 151,266 | 222,192 | 235,179 |
| Cash | 158,029 | 137,980 | 157,637 |
| Current Liabilities | 150,321 | 230,309 | 264,591 |
| Long Term Debt | 253,281 | 297,797 | 294,601 |
| Provisions | - | - | - |
| Minorities | - | - | - |
| Total Shareholders Equity | 643,821 | 624,004 | 655,222 |
| KEY RATIOS | |||
| Operating Margin(%) | 14.63 | 14.07 | 13.55 |
| Return on Equity Capital(%) | 9.99 | 10.36 | 10.96 |
| Net Profit Margin | 10.28 | 10.28 | 10.06 |
| Current Ratio | 3.06 | 2.15 | 2.05 |
| Debt to Capital at Book | 0.29 | 0.35 | 0.35 |
World'Vest Base, Inc.© 2023
Under no circumstances this document is to be used or considered as an offer to sell, or a solicitation of any offer to buy, any security. While information contained herein has been obtained from sources believed to be reliable, WVB does not represent that it is accurate or complete and it should not be relied upon as such.
1335, North Dearborn Parkway, Chicago, IL 60610
Tel: +1-312-922-4201 | Fax: 1-312-922-3277 | Email: inforequest@wvb.com
Financial Data Owned and Supplied by World'vest Base Inc. Copyright , All Rights Reserved.
| Company | Date announced |
To those registered by |
To be paid on |
Dividend | Ex-Dates |
| 13 Aug 2020 | 01 Sep 2020 | 11 Sep 2020 | Interim Single Tier 0.5sen | 28 Aug 2020 | |
| 02 Oct 2019 | 16 Oct 2019 | 14 Nov 2019 | Interim 1sen | 15 Oct 2019 | |
| 13 Jun 2019 | 27 Jun 2019 | 26 Jul 2019 | Final Single Tier 4sen | 26 Jun 2019 | |
| 08 Apr 2021 | 22 Apr 2021 | 21 May 2021 | Second interim dividend of RM0.06 per ordinary share | 21 Apr 2021 | |
| 30 Jun 2020 | 14 Jul 2020 | 12 Aug 2020 | Final 5sen | 13 Jul 2020 | |
| 17 Aug 2021 | 01 Sep 2021 | 15 Sep 2021 | First Interim Single-Tier Dividend of 0.5 sen per ordinary share | 30 Aug 2021 | |
| 16 Aug 2022 | 30 Aug 2022 | 14 Sep 2022 | First Interim Dividend of 0.5 sen per ordinary share | 29 Aug 2022 | |
| 27 Mar 2023 | 10 Apr 2023 | 09 May 2023 | Second Interim Dividend of 1.8 sen per ordinary share | 07 Apr 2023 | |
| 24 Aug 2023 | 11 Sep 2023 | 22 Sep 2023 | First Interim Dividend of 0.5 sen per ordinary share tax exempted under the single-tier system in respect of the financial year ending 31 December 2023 | 08 Sep 2023 |
